Ubiquitination is the first step of the ubiquitin-proteasome pathway that regulates cells for their homeostatic functions and is an enzymatic, protein post-translational modification process in which ubiquitin is transferred to a target protein substrate by a set of three ubiquitin enzymes (Weissman ., 2011; Bhattacharyya , 2014; Ristic ., 2014). Given the importance of this process, it is plausible that ubiquitination is under strict control by many factors and that the regulatory machineries are protein-specific. An assay for the detection of a specific protein ubiquitination will enable us to examine whether a factor has a function to regulate the ubiquitination of this protein. Here we describe a protocol that detects the ubiquitination status of the human REST4 protein in cultured cells, a neural alternative splicing isoform of REST (RE-1 silencing transcription factor), that antagonizes the repressive function of REST on neural differentiation and neuron formation. Using this protocol, we show that the telomere binding protein TRF2 stabilizes the expression of the human REST4 by inhibiting its ubiquitination. This indicates that TRF2 plays a positive role in neural differentiation (Ovando-Roche ., 2014). This protocol is also useful for the detection of ubiquitination of other proteins of interest.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524179 | PMC |
http://dx.doi.org/10.21769/BioProtoc.1525 | DOI Listing |
Neuro Oncol
February 2024
Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Background: Effective control of brain metastasis remains an urgent clinical need due a limited understanding of the mechanisms driving it. Although the gain of neuro-adaptive attributes in breast-to-brain metastases (BBMs) has been described, the mechanisms that govern this neural acclimation and the resulting brain metastasis competency are poorly understood. Herein, we define the role of neural-specific splicing factor Serine/Arginine Repetitive Matrix Protein 4 (SRRM4) in regulating microenvironmental adaptation and brain metastasis colonization in breast cancer cells.
View Article and Find Full Text PDFComput Struct Biotechnol J
December 2022
LifeB, FGP - NCBR, Faculty of Science, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic.
The RE1-Silencing Transcription factor (REST) is essential for neuronal differentiation. Here, we report the first 18.5-angstrom electron microscopy structure of human REST.
View Article and Find Full Text PDFCancer Res
September 2021
Department of Urology, University of Washington, Seattle, Washington.
Neuroendocrine (NE) differentiation in metastatic castration-resistant prostate cancer (mCRPC) is an increasingly common clinical feature arising from cellular plasticity. We recently characterized two mCRPC phenotypes with NE features: androgen receptor (AR)-positive NE-positive amphicrine prostate cancer (AMPC) and AR-negative small cell or neuroendocrine prostate cancer (SCNPC). Here, we interrogated the regulation of RE1-silencing transcription factor (REST), a transcriptional repressor of neuronal genes, and elucidated molecular programs driving AMPC and SCNPC biology.
View Article and Find Full Text PDFNeuroscience
August 2019
Laboratory of Protein Science, Proteomics and Epigenetic Signaling (PPES), Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium. Electronic address:
Neuroglobin (Ngb) is a REST/NRSF-regulated protein, active in reactive oxygen species detoxification and cytochrome c inhibition, which provides a beneficial outcome in pathologies as Alzheimer's disease and strokes. Considering that oxidative stress and cell death are typical hallmarks of amyotrophic lateral sclerosis (ALS), we sought to explore Ngb's involvement along this disease progression. Ngb transcription was detected to be two-fold down-regulated in late-stage SOD mice, similarly as previously described for Alzheimer disease.
View Article and Find Full Text PDFDrug Des Devel Ther
October 2018
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
Background/aim: Repressor element silencing transcription factor () is a transcription repressor, expressed in several malignancies. This study aims to evaluate the prognostic values of and its splicing variant in glioma, and investigate the potential correlation between and .
Methods: and expression values were evaluated by qRT-PCR in 89 patients with gliomas and 10 with normal brain tissues.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!